The CRISPR technology market is experiencing robust growth, with its revenue estimated to be worth $3.4 billion in 2023, and poised to reach an impressive $7.1 billion by 2028, reflecting a compound annual growth rate (CAGR) of 15.6% during this period. This remarkable expansion can be attributed to several key factors driving the industry's momentum. Download PDF...